Achieve Life Sciences, Inc.
ACHV
$2.24
$0.062.75%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.89M | 4.86M | 3.32M | 3.18M | 2.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.19M | 12.47M | 8.43M | 5.98M | 4.39M |
| Operating Income | -12.19M | -12.47M | -8.43M | -5.98M | -4.39M |
| Income Before Tax | -12.36M | -12.51M | -8.46M | -6.49M | -5.48M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.36M | -12.51M | -8.46M | -6.49M | -5.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.36M | -12.51M | -8.46M | -6.49M | -5.48M |
| EBIT | -12.19M | -12.47M | -8.43M | -5.98M | -4.39M |
| EBITDA | -12.13M | -12.41M | -8.37M | -5.93M | -4.33M |
| EPS Basic | -0.36 | -0.36 | -0.25 | -0.26 | -0.26 |
| Normalized Basic EPS | -0.22 | -0.22 | -0.15 | -0.16 | -0.15 |
| EPS Diluted | -0.36 | -0.36 | -0.25 | -0.26 | -0.26 |
| Normalized Diluted EPS | -0.22 | -0.22 | -0.15 | -0.16 | -0.15 |
| Average Basic Shares Outstanding | 34.51M | 34.36M | 34.32M | 25.05M | 21.17M |
| Average Diluted Shares Outstanding | 34.51M | 34.36M | 34.32M | 25.05M | 21.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
